Science Explorer Back to mapMap
Discussion
Company · Princeton · United States

Genmab (United States)

genmab.comROR OpenAlex
World rank, 2022-now
#21,033
of 22,385 · #29,201 all time
Rank in United States
#3,111
of 3,332
Research works
178
▲ 246% vs 2018-21
Citations
2.2k
12.6 per fractional work
Top-10% rate
8.3%
all institutions 10.0%
vs its own fields
0.95×
1.00× is exactly expected
Open access
51%
world 40%
International
53%
world 18%
Genmab (United States)

Which fields of science does Genmab (United States) work in?

In 2022-now, 60% of research at Genmab (United States) is in Health Sciences, 24% in Life Sciences. Its largest fields are Medicine (59%), Biochemistry, Genetics and Molecular Biology (17%), Immunology and Microbiology (7%). It does 2.4× the world's share of Health Sciences.

Health Sciences: 66 fractional works · 59.5% of its workMedicine: 65 fractional works · 58.8% of its workOncology: 22 fractional works · 19.7% of its workRadiology, Nuclear Medicine and Imaging: 13 fractional works · 11.6% of its workPathology and Forensic Medicine: 10 fractional works · 9.4% of its workPulmonary and Respiratory Medicine: 5 fractional works · 4.2% of its workGenetics: 3 fractional works · 3.1% of its workReproductive Medicine: 2 fractional works · 1.4% of its workPublic Health, Environmental and Occupational Health: 1 fractional works · 1.2% of its workObstetrics and Gynecology: 1 fractional works · 1.2% of its workHematology: 1 fractional works · 1.1% of its workOtorhinolaryngology: 1 fractional works · 1.0% of its workEpidemiology: 1 fractional works · 0.9% of its workNeurology: 1 fractional works · 0.8% of its workHealth Informatics: 1 fractional works · 0.7% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workPhysiology: 0 fractional works · 0.4% of its workPsychiatry and Mental health: 0 fractional works · 0.3% of its workOphthalmology: 0 fractional works · 0.3% of its workDermatology: 0 fractional works · 0.3% of its workInfectious Diseases: 0 fractional works · 0.3% of its workSurgery: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.4% of its workDentistry: 0 fractional works · 0.3% of its workPeriodontics: 0 fractional works · 0.3% of its workHealth Professions: 0 fractional works · 0.2% of its workVeterinary: 0 fractional works · 0.1% of its workNursing: 0 fractional works · 0.1% of its workLife Sciences: 27 fractional works · 24.4% of its workBiochemistry, Genetics and Molecular Biology: 18 fractional works · 16.7% of its workMolecular Biology: 10 fractional works · 9.5% of its workCancer Research: 4 fractional works · 3.4% of its workBiotechnology: 2 fractional works · 1.4% of its workBiophysics: 1 fractional works · 1.2% of its workGenetics: 1 fractional works · 0.7% of its workEndocrinology: 0 fractional works · 0.3% of its workCell Biology: 0 fractional works · 0.3% of its workImmunology and Microbiology: 7 fractional works · 6.7% of its workImmunology: 7 fractional works · 6.6% of its workSmaller subfields together: 0 fractional works · 0.1% of its workAgricultural and Biological Sciences: 1 fractional works · 0.7% of its workGeneral Agricultural and Biological Sciences: 0 fractional works · 0.5% of its workFood Science: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.3% of its workPharmaceutical Science: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 0.1% of its workPhysical Sciences: 12 fractional works · 10.6% of its workComputer Science: 6 fractional works · 5.4% of its workArtificial Intelligence: 4 fractional works · 3.9% of its workComputational Theory and Mathematics: 1 fractional works · 0.7% of its workComputer Vision and Pattern Recognition: 1 fractional works · 0.5% of its workInformation Systems: 0 fractional works · 0.3% of its workEngineering: 2 fractional works · 1.6% of its workBiomedical Engineering: 1 fractional works · 0.5% of its workAerospace Engineering: 0 fractional works · 0.3% of its workMechanics of Materials: 0 fractional works · 0.2% of its workMechanical Engineering: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.3% of its workMathematics: 2 fractional works · 1.4% of its workStatistics and Probability: 1 fractional works · 0.8% of its workModeling and Simulation: 1 fractional works · 0.6% of its workEnvironmental Science: 2 fractional works · 1.4% of its workEnvironmental Chemistry: 1 fractional works · 0.9% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPhysics and Astronomy: 1 fractional works · 0.6% of its workAstronomy and Astrophysics: 1 fractional works · 0.6% of its workEnergy: 0 fractional works · 0.2% of its workChemistry: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.0% of its workSocial Sciences: 6 fractional works · 5.5% of its workArts and Humanities: 2 fractional works · 1.5% of its workArcheology: 1 fractional works · 0.9% of its workClassics: 0 fractional works · 0.3% of its workHistory: 0 fractional works · 0.3% of its workDecision Sciences: 2 fractional works · 1.4% of its workInformation Systems and Management: 2 fractional works · 1.4% of its workSmaller subfields together: 0 fractional works · 0.0% of its workSocial Sciences: 1 fractional works · 1.2% of its workSafety Research: 1 fractional works · 0.9% of its workSociology and Political Science: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 1 fractional works · 1.0% of its workEconomics and Econometrics: 1 fractional works · 1.0% of its workPsychology: 0 fractional works · 0.4% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workBusiness, Management and Accounting: 0 fractional works · 0.0% of its workALL ITS WORKGenmab (UnitedStates)111fractional works, 2022-now
Life Sciences24%Physical Sciences11%Health Sciences60%Social Sciences6%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 24 fields, with their numbers
    1. Medicine6558.8%
    2. Dentistry00.3%
    3. Health Professions00.2%
    4. Veterinary00.1%
    5. Nursing00.1%
    1. Biochemistry, Genetics and Molecular Biology1816.7%
    2. Immunology and Microbiology76.7%
    3. Agricultural and Biological Sciences10.7%
    4. Pharmacology, Toxicology and Pharmaceutics00.3%
    5. Neuroscience00.1%
    1. Computer Science65.4%
    2. Engineering21.6%
    3. Mathematics21.4%
    4. Environmental Science21.4%
    5. Physics and Astronomy10.6%
    6. Energy00.2%
    7. Chemistry00.1%
    8. Materials Science00.0%
    1. Arts and Humanities21.5%
    2. Decision Sciences21.4%
    3. Social Sciences11.2%
    4. Economics, Econometrics and Finance11.0%
    5. Psychology00.4%
    6. Business, Management and Accounting00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Genmab (United States) specialise in?

Where its research is concentrated relative to its size: Oncology takes 17.5× the share of its output that it takes of world research.

  1. OncologySubfield · 21.8 works17×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.14× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.13× its world share, 18 worksBiochemistry, Geneti…Immunology and Microbiology: 6.65× its world share, 7 worksImmunology and Micro…Neuroscience: 0.03× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.77× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.08× its world share, 0 worksChemistryComputer Science: 0.69× its world share, 6 worksComputer ScienceEnergy: 0.16× its world share, 0 worksEnergyEngineering: 0.10× its world share, 2 worksEngineeringEnvironmental Science: 0.27× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.01× its world share, 0 worksMaterials ScienceMathematics: 1.18× its world share, 2 worksMathematicsPhysics and Astronomy: 0.27× its world share, 1 worksPhysics and AstronomyDentistry: 0.56× its world share, 0 worksDentistryHealth Professions: 0.09× its world share, 0 worksHealth ProfessionsMedicine: 3.06× its world share, 65 worksMedicineNursing: 0.15× its world share, 0 worksNursingVeterinary: 0.66× its world share, 0 worksVeterinaryArts and Humanities: 0.52× its world share, 2 worksArts and HumanitiesBusiness, Management and Accounting: 0.01× its world share, 0 worksBusiness, Management…Decision Sciences: 1.43× its world share, 2 worksDecision SciencesEconomics, Econometrics and Finance: 0.48× its world share, 1 worksEconomics, Econometr…Psychology: 0.13× its world share, 0 worksPsychologySocial Sciences: 0.09× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 6.7×. Every wedge is a field page.

All 24 fields, with their numbers
  1. Immunology and Microbiology6.65×7 works
  2. Biochemistry, Genetics and Molecular Biology3.13×18 works
  3. Medicine3.06×65 works
  4. Decision Sciences1.43×2 works
  5. Mathematics1.18×2 works
  6. Pharmacology, Toxicology and Pharmaceutics0.77×0 works
  7. Computer Science0.69×6 works
  8. Veterinary0.66×0 works
  9. Dentistry0.56×0 works
  10. Arts and Humanities0.52×2 works
  11. Economics, Econometrics and Finance0.48×1 works
  12. Environmental Science0.27×2 works
  13. Physics and Astronomy0.27×1 works
  14. Energy0.16×0 works
  15. Nursing0.15×0 works
  16. Agricultural and Biological Sciences0.14×1 works
  17. Psychology0.13×0 works
  18. Engineering0.10×2 works
  19. Health Professions0.09×0 works
  20. Social Sciences0.09×1 works
  21. Chemistry0.08×0 works
  22. Neuroscience0.03×0 works
  23. Materials Science0.01×0 works
  24. Business, Management and Accounting0.01×0 works

Who are the top researchers at Genmab (United States)?

Ranked on the quality score, Brandon W. Higgs, Han Si and Sriram Sridhar lead among researchers whose main affiliation is Genmab (United States).

  1. 1 Brandon W. Higgs United States · #142,412 worldwide 9.3k citations · 328 works
  2. 2 Han Si United States · #165,572 worldwide 5.2k citations · 137 works
  3. 3 Sriram Sridhar United States · #166,466 worldwide 3.3k citations · 71 works
  4. 4 Suzana S. Couto United States · #215,179 worldwide 4.4k citations · 140 works
  5. 5 Maria Jure‐Kunkel United States · #418,268 worldwide 2.5k citations · 265 works
  6. 6 Jimin Zhang United States · #994,030 worldwide 2.6k citations · 69 works
  7. 7 Mariana Sacchi United States · #997,791 worldwide 1.6k citations · 63 works
  8. 8 Mark Fereshteh United States · #1,040,367 worldwide 2.3k citations · 82 works
  9. 9 Jordan Samuel Blum United States · #1,176,435 worldwide 2.4k citations · 31 works
  10. 10 Paweł Dudzic United States · #1,183,835 worldwide 219 citations · 25 works
All ranked researchers at Genmab (United States)

What are the most cited papers from Genmab (United States)?

The most cited paper from Genmab (United States) is "Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma" (Thierry T.F. Facon et al., 2019), with 1,022 citations. Next come "Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study" (973) and "Immunoglobulin G4: an odd antibody" (836).

Most cited papers
#PaperReleasedCitations
1 Daratumumab plus Lenalidomide and Dexamethasone for Untreated Myeloma Thierry T.F. Facon et al. · New England Journal of Medicine Open access 29 May 2019 1,022
2 Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study Philippe Moreau et al. · The Lancet Open access 3 Jun 2019 973
3 Immunoglobulin G4: an odd antibody Rob C. Aalberse, Steven O. Stapel, Janine Schuurman et al. · Clinical & Experimental Allergy 16 Feb 2009 836
4 Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis Efstathios Kastritis et al. · New England Journal of Medicine Open access 30 Jun 2021 703
5 Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial Catherine Thiéblemont et al. · Journal of Clinical Oncology Open access 22 Dec 2022 577
All 60 most cited papers, with filters and sorting

Which keywords describe research at Genmab (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Lymphoma, Rituximab, Immunotherapy, Cancer Immunotherapy, Monoclonal Antibodies, Tumor Regression, PET Imaging and Classification.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Lymphoma18▲ 101×2 topics
  2. Rituximab12▲ 77×2 topics
  3. Immunotherapy12▲ 15×11 topics
  4. Cancer Immunotherapy10▲ 62×3 topics
  5. Monoclonal Antibodies10▲ 104×3 topics
  6. Tumor Regression10▲ 81×2 topics
  7. PET Imaging10▲ 54×3 topics
  8. Classification9▲ 19×1 topic
  9. Molecular Profiling9▲ 89×1 topic
  10. Machine Learning9▲ 2.5×13 topics
  11. CAR T Cells9▲ 106×1 topic
  12. Chimeric Antigen Receptor9▲ 106×1 topic
  13. Glycosylation8▲ 65×3 topics
  14. Chemotherapy8▲ 9.9×16 topics
  15. Therapeutic Antibodies8▲ 101×2 topics
  16. Tumor Microenvironment8▲ 15×7 topics
  17. Antibody Engineering7▲ 122×1 topic
  18. Fc Receptors7▲ 122×1 topic
  19. Immune Checkpoint Blockade6▲ 49×1 topic
  20. PD-1 and PD-L16▲ 49×1 topic
  21. Targeted Therapy6▲ 24×5 topics
  22. Precision Medicine6▲ 10×5 topics
  23. Clinical Trials5▲ 6.6×8 topics
  24. Medical Imaging5▲ 8.1×3 topics
  25. Prognostic Factors5▲ 9.8×7 topics
  26. Predictive Modeling4▲ 14×2 topics
  27. Feature Extraction4▲ 7.7×2 topics
  28. Texture Analysis4▲ 16×2 topics
  29. Quantitative Analysis4▲ 16×2 topics
  30. Gene Expression4▲ 5.3×8 topics
  31. Radiomics4▲ 29×1 topic
  32. Tumor Heterogeneity4▲ 29×1 topic
  33. Therapeutic Targets3▲ 20×2 topics
  34. Biopharmaceuticals3▲ 52×3 topics
  35. Chronic Lymphocytic Leukemia3▲ 65×1 topic
  36. Genomic Aberrations3▲ 65×1 topic
  37. Immunogenicity3▲ 62×2 topics
  38. Cancer Genomics3▲ 36×1 topic
  39. Genomic Instability3▲ 23×2 topics
  40. Mutational Signatures3▲ 36×1 topic

Which research topics does Genmab (United States) publish most on?

By volume in 2022-now: Lymphoma Diagnosis and Treatment, CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research and Cancer Immunotherapy and Biomarkers.

Lymphoma Diagnosis and Treatment: 9 fractional worksCAR-T cell therapy research: 9 fractional worksMonoclonal and Polyclonal Antibodies Research: 7 fractional worksCancer Immunotherapy and Biomarkers: 6 fractional worksRadiomics and Machine Learning in Medical Imaging: 4 fractional worksChronic Lymphocytic Leuk…3Chronic Lymphocytic Leukemia Research: 3 fractional worksCancer Genomics and Diagnostics: 3 fractional worksBiosimilars and Bioanalytical Methods: 2 fractional worksHER2/EGFR in Cancer Research: 2 fractional worksLung Cancer Treatments and Mutations: 2 fractional works
Pathology and Forensic MedicineOncologyRadiology, Nuclear Medicine and ImagingGenetics3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 9 works
  2. 2 CAR-T cell therapy research Oncology 9 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 7 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 6 works
  5. 5 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 4 works
  6. 6 Chronic Lymphocytic Leukemia Research Genetics 3 works
  7. 7 Cancer Genomics and Diagnostics Cancer Research 3 works
  8. 8 Biosimilars and Bioanalytical Methods Immunology 2 works
  9. 9 HER2/EGFR in Cancer Research Oncology 2 works
  10. 10 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 2 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available51.2%not open48.8%

World: 40% of research is openly available.

with international co-authors53.3%domestic only46.7%

World: 18% is written across borders.

How has Genmab (United States)'s research output changed?

Output in 2022-2025 was 246% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Genmab (United States) as a percentage of every work published that year, 0.00039% in 2024.

still counting0.00025%0.00050%0.00075%Genmab (United States)0.00046% in 20251990200020102020

Fractional works of Genmab (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Princeton

All research institutions in Princeton

Share Genmab (United States)'s ranking

Genmab (United States) on Science Explorer

A card with Genmab (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Genmab (United States). Posts are plain text and can be reported.